Key facts
- This page summarizes Zack Lynch's Form 4 filing for Pear Therapeutics, Inc..
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Dec 2021, 16:23.
Zack Lynch - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 03 Dec 2021
- Net transaction value
- +$100,000
- Reporting owner signature
- /s/ Stacie S. Aarestad, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Zack Lynch filed Form 4 for Pear Therapeutics, Inc. on 07 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$100,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PEARQ
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +1,084,914
- Change %
- Price
- Shares after
- 1,084,914
- Date
- 03 Dec 2021
- Ownership
- by JAZZ Human Performance Opportunity Fund, L.P.
- Footnotes
- F1, F3
PEARQ
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +9,671,673
- Change %
- Price
- Shares after
- 9,671,673
- Date
- 03 Dec 2021
- Ownership
- by JAZZ Human Performance Technology Fund, L.P.
- Footnotes
- F2, F3
PEARQ
transaction
Class A Common Stock
Award
- Transaction value
- $100,000
- Shares
- +10,000
- Change %
- +0.1%
- Price
- $10.00*
- Shares after
- 9,681,673
- Date
- 03 Dec 2021
- Ownership
- by JAZZ Human Performance Technology Fund, L.P.
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PEARQ
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +29,448
- Change %
- Price
- Shares after
- 29,448
- Date
- 03 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,448
- Exercise price
- $0.0200
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 736,827 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Opportunity Fund, L.P.
Footnote F2
Received in accordance with the terms of the Business Combination Agreement in exchange for 6,568,585 shares of preferred stock of Private Pear previously held by JAZZ Human Performance Technology Fund, L.P.
Footnote F3
The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of the Reporting Person's pecuniary interest therein.
Footnote F4
On June 21, 2021, Issuer entered into subscription agreements with certain investors (the "PIPE Investors") pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $10.00 per share in connection with, and conditioned upon, the substantially concurrent consummation of certain transactions, including the Business Combination. As one of the PIPE Investors, on December 3, 2021, JAZZ Human Performance Technology Fund, L.P. acquired 10,000 shares of Issuer common stock for $10.00 per share.
Footnote F5
100% of the shares subject to this option are fully vested and exercisable.
Footnote F6
Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 20,000 shares of common stock of Private Pear for $0.02 per share.